The all around news is good for CERS- Expecting the first and only pathogen activation in the US to gain momentum and get back to some of its old glory days ... again potential buy out
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
